Get started
Author

Jeliazko Iliev Arabadjiev

Observed names: Arabadjiev, Jeliazko, J. Arabadjiev, Jeliazko Arabadjiev, Jeliazko Arabadjiev Желязко Арабаджиев, Jeliazko I. Arabadjiev
ORCID: 0000-0003-2440-2760
Observed ORCID: 0000-0003-2440-2760
OpenAlex ID: A5015801724
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer
2020 · Mila P. Petrova, Mariyana I. Eneva, et al. · BioScience Trends · 59
PDF
Engaging European society at the forefront of cancer research and care: How discussions at the 5th Gago Conference on European Science policy led to the Heidelberg Manifesto
2023 · Michael Baumann, Julio Celis, et al. · Molecular Oncology · 9
PDF
Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review
2022 · Tanya Zlatanova, Jeliazko Arabadjiev, et al. · Frontiers in Oncology · 4
PDF
Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study
2025 · Alexandra C. Preda, Rossitza Krasteva, et al. · Cancer Treatment and Research Communications · 3
PDF
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting
2023 · R. Gencheva, M. Petrova, et al. · Cancer Reports · 3
PDF
Alteration of Mesenchymal Stem Cells Isolated from Glioblastoma Multiforme under the Influence of Photodynamic Treatment
2023 · Kalina Tumangelova-Yuzeir, Krassimir Minkin, et al. · Current Issues in Molecular Biology · 3
PDF
Incidence, patient characteristics and treatment patterns of early-stage triple-negative breast cancer (TNBC) in Bulgaria: A retrospective analysis based on real-world data
2025 · Jeliazko Arabadjiev, Assia Konsoulova, et al. · Pharmacia · 2
The prognostic role of markers of systemic inflammation in patients with metastatic lung cancer receiving immunotherapy: A comprehensive review of the literature
2024 · Tanya Zlatanova, Jeliazko Arabadjiev · Pharmacia · 2
PDF
Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated in routine Bulgarian clinical practice
2023 · Manoela Manova, Jeliazko Arabadjiev, et al. · Biotechnology & Biotechnological Equipment · 2
PDF
Real-World Evidence of Atezolizumab Efficacy as Part of First-Line Treatment for Extensive-Stage SCLC in Bulgaria
2026 · Manoela Manova, Boryana Ivanova, et al. · Cancers · 1
PDF
Real-world evidence of first-line osimertinib effectiveness in Bulgarian patients: a retrospective analysis
2025 · Manoela Manova, Boryana Ivanova, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 1
PDF
Real-world effectiveness of dabrafenib and trametinib in patients with BRAF-positive melanoma treated in routine Bulgarian clinical practice
2024 · Alexandra Savova, Boryana Ivanova, et al. · Pharmacia · 1
PDF
Role of pharmacists in adherence in oncology patients
2024 · Zornitsa Mitkova, Stephanie Karanyotova, et al. · Biotechnology & Biotechnological Equipment · 1
Prevalence of Homologous Recombination Deficiency and Treatment Patterns in Patients with Newly Diagnosed Advanced Ovarian Cancer in Bulgaria: A Real-World Cohort Study (VALIDATE)
2026 · Jeliazko Arabadjiev, Krasimir Nikolov, et al. · Medicina
The journey of lung cancer patients through the health care system in Bulgaria: Insights from patient-reported outcomes
2026 · Jeliazko Arabadjiev, Rositsa Krasteva, et al. · Pharmacia
PDF
Parvovirus B19 DNA Detected in Ovarian Teratomatous Tissue in Anti-NMDAR Encephalitis: A Case Report
2026 · Trifon Valkov, Dobroslav Kyurkchiev, et al. · Viruses
PDF
P2.15.06 Best Practices and Process Variations of Lung Cancer Multi-Disciplinary Teams: Insights From Europe and Israel
2025 · H. Linardou, G. Galffy, et al. · Journal of Thoracic Oncology
P1.17.29 Access to Novel Therapies for the Treatment of NSCLC in 18 EU Member States
2025 · U. Janzic, O. Illini, et al. · Journal of Thoracic Oncology
Co-occurrence of lung adenocarcinoma and pulmonary fibrosis in a patient: A comprehensive case study and review of existing literature on the successful utilization of nintedanib
2023 · Tanya Zlatanova, Jeliazko Arabadjiev · Pharmacia
PDF
PI3KCA mutation prevalence and outcome among patients with metastatic breast cancer in Bulgaria treated with first-line endocrine therapy.
2023 · Radostina Gencheva, Savina Hadjidekova, et al. · Journal of Clinical Oncology
PDF
“Predictive and prognostic value of tumorinfiltrating lymphocytes in women with breast cancer”
2020 · Арабаджиев, Желязко, Arabadjiev, Jeliazko · Bulgarian Portal for Open Science
High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line.
2020 · Milla Petrova, Mariyana Eneva, et al. · Journal of Clinical Oncology
Predictive and Prognostic Value of Tumour-Infiltrating Lymphocytes in Women with Breast Cancer // Предиктивна и прогностична стойност на тумор-инфилтриращите лимфоцити при жени с рак на млечната жлеза
2020 · Jeliazko Arabadjiev Желязко Арабаджиев
Works count: 24
Citation count: 91
H-index: 3
I10-index: 1
Year
Topic
Type